|
2024
|
Invention
|
Fused heterocycles for treating neurodegenerative diseases. Disclosed herein are aspects of compo... |
|
|
Invention
|
Nk cells or t cells expressing chimeric hematopoietic growth factor receptors and methods of use.... |
|
|
Invention
|
Brincidofovir for treatment of multiple sclerosis. The invention features methods of treating mul... |
|
|
Invention
|
Bioreactor system. A bioreactor vessel platform for submersion in a bioreactor vessel or petri di... |
|
|
Invention
|
Analogues of n-lactoyl-phenylalanine, methods of synthesis, and methods of use. N-Lactoyl-Phenyla... |
|
|
Invention
|
A molecular scaffold for depleting hrpn13 and a select group of ken box proteins. The invention p... |
|
|
Invention
|
Gait assistance systems and methods of control thereof. Determining predicted torque values for a... |
|
|
Invention
|
Stabilized sars-cov-2 s antigens. Provided herein are engineered protein comprising stabilized co... |
|
|
Invention
|
Human parainfluenza virus immunogenic molecules. Disclosed are live-attenuated human parainfluenz... |
|
|
Invention
|
Codon-optimized human npc1 genes for the treatment of niemann-pick type c1 deficiency and related... |
|
|
Invention
|
Viral strain serology assays. The invention relates to methods and kits for determining a SARS-Co... |
|
|
Invention
|
Dopamine d3 receptor selective antagonists/partial agonists and uses thereof.
Disclosed herein a... |
|
|
Invention
|
Polyfluorinated thalidomide analogs and uses thereof. Polyfluorinated thalidomide analogs have a ... |
|
|
Invention
|
Method and system for rapid spectral unmixing using spectrally interpolated background reduction.... |
|
|
Invention
|
Rapid method for producing antibodies. The present disclosure relates to a rapid method for produ... |
|
|
Invention
|
Identification of sequence variants of the ervmer34-1 sequence family and use in anti-cancer ther... |
|
|
Invention
|
Bispecific antibodies that broadly target coronaviruses. Disclosed are bispecific antibodies, inc... |
|
|
Invention
|
2b serotonin receptor antagonists, pharmaceutical compositions thereof, and methods of use thereo... |
|
|
Invention
|
Kinase inhibitors. Disclosed is a class of kinase inhibitors of formula (I) or formula (II). Rela... |
|
|
Invention
|
Fully human monoclonal antibodies and chimeric antigen receptors against cd276 for the treatment ... |
|
|
Invention
|
Humanized 40h3 antibody. e.ge.g., humanized monoclonal antibodies and antigen binding fragments) ... |
|
|
Invention
|
Uses of iron chelators for treating stuttering. Provided herein are uses of iron chelators to tre... |
|
|
Invention
|
Potent and selective dopamine d3 receptor antagonists. 33 receptor modulators, inclusive of antag... |
|
|
Invention
|
Shipping container for system supporting live cells. A shipping container for the support and shi... |
|
|
Invention
|
Genetically detoxified mutant of neisseria and outer membrane vesicle (omv) vaccine. Disclosed ar... |
|
|
Invention
|
Novel malaria vaccine comprising ama1 and ron2 antigens. Plasmodium yoeliiPlasmodium falciparumPl... |
|
|
Invention
|
T cell receptors targeting ras with g12d, g12r, or g12v mutation. Disclosed are isolated or purif... |
|
|
Invention
|
Epidithiodiketopiperazine analogs and methods of use. Epidithiodiketopiperazine (ETP) analogs and... |
|
|
Invention
|
Method and apparatus for cryogenic-electron microscopy sample preparation. An apparatus for prepa... |
|
|
Invention
|
Vaccine for cats to block toxoplasma oocyst shedding and transmission. Apicomplexa or EuglenozoaT... |
|
|
Invention
|
Hiv-1 envelope triple tandem trimers and their use. Immunogens comprising a recombinant HIV-1 Env... |
|
|
Invention
|
Copiparvovirus genetic vector platform. In a first aspect, the invention provides a genetic vecto... |
|
|
Invention
|
Tyrosinase gene therapy for oculocutaneous albinism type 1a. TyrosinaseBESTROPHINVMD2TyrosinaseTy... |
|
|
Invention
|
Human monoclonal antibodies that target the rh5 complex of blood-stage plasmodium falciparum. P. ... |
|
|
Invention
|
Recombinant murine pneumonia virus expressing severe acute respiratory syndrome coronavirus 2 (sa... |
|
|
Invention
|
Using machine learning and/or neural networks to validate stem cells and their derivatives (2-d c... |
|
|
Invention
|
Single domain antibodies that specifically bind the s2 subunit of sars-cov-2 spike protein and co... |
|
|
Invention
|
Bicistronic chimeric antigen receptors and their uses.
An embodiment of the invention provides c... |
|
|
Invention
|
Treatment of hypoparathyroidism using triphenyl calcilytic compounds. The present disclosure prov... |
|
|
Invention
|
Systems and methods for multichannel individualized stimulation therapy. Methods and systems are ... |
|
|
Invention
|
Synthetic mmab genes and aav vectors to treat cobalamin b deficiency. synMMABsynMMABsynMMAB polyn... |
|
|
Invention
|
Systems and methods for patterned multi-slice excitation in magnetic resonance imaging. Various m... |
|
|
Invention
|
1-thioxo-2,4-dihydrothieno[2,3-e][1,2,4]triazolo[4,3-a]pyrimidin-5(1 h)-one derivatives as allost... |
|
|
Invention
|
Enzymatic radiosynthesis of deoxy-[18f]fluorocellobiose and deoxy-[18f]fluorocellotriose. Enzymat... |
|
|
Invention
|
T cell receptors targeting y220c or r175h mutation in p53. Disclosed are isolated or purified T c... |
|
|
Invention
|
Methods of preparing anti-human papillomavirus antigen t cells.
Disclosed are methods of prepari... |
|
2022
|
Invention
|
Improved gene therapy constructs for the treatment of propionic acidemia caused by mutations in p... |
|
|
Invention
|
Next generation transpososomes.
Disclosed herein is a modified transposase, comprising a core pi... |
|
|
Invention
|
Aqp1 gene therapy to prevent radiation induced salivary hypofunction.
Administration of aquapori... |
|
2021
|
Invention
|
Therapeutics for the treatment of neurodegenerative disorders.
Antisense oligonucleotides (ASOs)... |
